<?xml version="1.0" encoding="UTF-8"?>
<p>The diagnostic criteria for epidemic parotitis were based on the “Epidemic parotitis diagnostic criteria, WS270-2007” which was approved by the Ministry of Health, People's Republic of China, and issued on October 15, 2007 [
 <xref rid="B18" ref-type="bibr">18</xref>]. Clinically diagnosed cases were defined using the following criteria: (1) swelling, pain, and/or amplifying pain of the unilateral, bilateral parotid glands or other saliva glands during mouth opening, chewing, and eating acidic food, (2) symptoms like fever, headache, fatigue, and loss of appetite, (3) contacting with individuals infected by epidemic parotitis 14 to 28 days before disease onset, and/or those living in a region with an ongoing epidemic parotitis and having symptoms like fever, headache, fatigue, and loss of appetite, and (4) elevated serum and urine amylase levels and/or changes of cerebral spinal fluid indicating the presence of viral meningitis. Laboratory-confirmed cases were further identified from clinically confirmed cases by the following criteria: (1) elevated epidemic parotitis virus-specific IgM antibodies in the serum, (2) a 4-fold or higher elevation of epidemic parotitis virus-specific IgG antibody titers during the recovery or acute phases, and/or (3) isolated epidemic parotitis virus from body fluids, such as the saliva, urine, and cerebral spinal fluid.
</p>
